|
|
Volumn 36, Issue 7, 2004, Pages 2090-2091
|
|
Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DRUG EFFECT;
DRUG SAFETY;
DRUG WITHDRAWAL;
HIGH RISK POPULATION;
HUMAN;
INCIDENCE;
INTERMETHOD COMPARISON;
KIDNEY GRAFT REJECTION;
LEUKOPENIA;
LYMPHOPROLIFERATIVE DISEASE;
PARAMETER;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROTEINURIA;
RANDOMIZED CONTROLLED TRIAL;
RETROSPECTIVE STUDY;
SIDE EFFECT;
AZATHIOPRINE;
CREATININE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 7044253094
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.08.104 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (3)
|
